Variant report
Variant | nsv522079 |
---|---|
Chromosome Location | chr2:34398738-34403344 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:34401156..34402823-chr2:34426410..34428532,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192496446 | chr2:34399203-34399204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574710737 | chr2:34399232-34399233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6719943 | chr2:34399249-34399250 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs34946063 | chr2:34399269-34399270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563316592 | chr2:34399288-34399289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77873716 | chr2:34399320-34399321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141687515 | chr2:34399349-34399350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559538337 | chr2:34399409-34399410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368307413 | chr2:34399428-34399429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537346642 | chr2:34399432-34399433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527879602 | chr2:34399497-34399498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548044587 | chr2:34399520-34399521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200899557 | chr2:34399522-34399523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76302385 | chr2:34399538-34399539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530448896 | chr2:34399559-34399560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76015591 | chr2:34399564-34399565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570043478 | chr2:34399620-34399621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75344016 | chr2:34399627-34399628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150104923 | chr2:34399629-34399630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565873361 | chr2:34399642-34399643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73929626 | chr2:34399660-34399661 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs184417512 | chr2:34399676-34399677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574616879 | chr2:34399710-34399711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138600443 | chr2:34399819-34399820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576956526 | chr2:34399887-34399888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556638788 | chr2:34399895-34399896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541119412 | chr2:34399937-34399938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552823223 | chr2:34399959-34399960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79313284 | chr2:34399960-34399961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112172870 | chr2:34400015-34400016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544682253 | chr2:34400021-34400022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs60830040 | chr2:34400033-34400034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369002050 | chr2:34400034-34400035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs386389896 | chr2:34400035-34400036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71409683 | chr2:34400036-34400037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10624822 | chr2:34400041-34400042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs397702583 | chr2:34400045-34400046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563540105 | chr2:34400053-34400054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528226727 | chr2:34400121-34400122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142797580 | chr2:34400130-34400131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531067704 | chr2:34400159-34400160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561548999 | chr2:34400196-34400197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573230960 | chr2:34401801-34401802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140717600 | chr2:34401835-34401836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561957227 | chr2:34401882-34401883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530996739 | chr2:34401894-34401895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544386216 | chr2:34401895-34401896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574931241 | chr2:34401928-34401929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371818540 | chr2:34401929-34401930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564620164 | chr2:34402027-34402028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34399200-34400200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr2:34401800-34402000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:34402000-34402800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:34402800-34403000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr2:34403000-34403800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |